These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 11169832)

  • 1. Correlation of three-dimensional gradient echo dynamic MR imaging with CT during hepatic arteriography in patients with hypervascular hepatocellular carcinomas: preliminary clinical experience.
    Yoshimitsu K; Honda H; Jimi M; Kuroiwa T; Irie H; Aibe H; Shinozaki K; Asayama Y; Shimada M; Masuda K
    J Magn Reson Imaging; 2001 Feb; 13(2):258-62. PubMed ID: 11169832
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distinguishing hypervascular pseudolesions of the liver from hypervascular hepatocellular carcinomas with gadoxetic acid-enhanced MR imaging.
    Motosugi U; Ichikawa T; Sou H; Sano K; Tominaga L; Muhi A; Araki T
    Radiology; 2010 Jul; 256(1):151-8. PubMed ID: 20574092
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of hypervascular hepatocellular carcinoma by dynamic magnetic resonance imaging with double-echo chemical shift in-phase and opposed-phase gradient echo technique: comparison with dynamic helical computed tomography imaging with double arterial phase.
    Noguchi Y; Murakami T; Kim T; Hori M; Osuga K; Kawata S; Okada A; Sugiura T; Tomoda K; Narumi Y; Nakamura H
    J Comput Assist Tomogr; 2002; 26(6):981-7. PubMed ID: 12488747
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic performance of gadoxetic acid (Primovist)-enhanced MR imaging versus CT during hepatic arteriography and portography for small hypervascular hepatocellular carcinoma.
    Yim SY; Park BJ; Um SH; Han NY; Sung DJ; Cho SB; Lee SH; Kim MJ; Jung JY; Kim JD; Seo YS; Kim DS; An H; Kim YH
    Medicine (Baltimore); 2016 Sep; 95(39):e4903. PubMed ID: 27684824
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preoperative detection of hepatocellular carcinoma: ferumoxides-enhanced mr imaging versus combined helical CT during arterial portography and CT hepatic arteriography.
    Choi D; Kim S; Lim J; Lee W; Jang H; Lee S; Lim H
    AJR Am J Roentgenol; 2001 Feb; 176(2):475-82. PubMed ID: 11159099
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Usefulness of combining sequentially acquired gadobenate dimeglumine-enhanced magnetic resonance imaging and resovist-enhanced magnetic resonance imaging for the detection of hepatocellular carcinoma: comparison with computed tomography hepatic arteriography and computed tomography arterioportography using 16-slice multidetector computed tomography.
    Kim YK; Kwak HS; Han YM; Kim CS
    J Comput Assist Tomogr; 2007; 31(5):702-11. PubMed ID: 17895780
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of hypervascular hepatocellular carcinoma by using spiral volumetric CT: comparison of US and MR imaging.
    Ueda K; Kitagawa K; Kadoya M; Matsui O; Takashima T; Yamahana T
    Abdom Imaging; 1995; 20(6):547-53. PubMed ID: 8580751
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of hemodynamic imaging findings of hypervascular hepatocellular carcinoma: comparison between dynamic contrast-enhanced magnetic resonance imaging using radial volumetric imaging breath-hold examination with k-space-weighted image contrast reconstruction and dynamic computed tomography during hepatic arteriography.
    Kurozumi M; Fujinaga Y; Kitou Y; Yamada A; Ohya A; Adachi Y; Tsukahara Y; Nickel MD; Maruyama K; Uehara T; Miyagawa SI; Kadoya M
    Jpn J Radiol; 2018 Apr; 36(4):295-302. PubMed ID: 29327116
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Small hypervascular hepatocellular carcinoma: limited value of portal and delayed phases on dynamic magnetic resonance imaging.
    Yu JS; Lee JH; Chung JJ; Kim JH; Kim KW
    Acta Radiol; 2008 Sep; 49(7):735-43. PubMed ID: 18608015
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of hepatocellular carcinoma: comparison of dynamic MR imaging with dynamic double arterial phase helical CT.
    Noguchi Y; Murakami T; Kim T; Hori M; Osuga K; Kawata S; Kumano S; Okada A; Sugiura T; Nakamura H
    AJR Am J Roentgenol; 2003 Feb; 180(2):455-60. PubMed ID: 12540451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Three-dimensional dynamic liver MR imaging using sensitivity encoding for detection of hepatocellular carcinomas: comparison with superparamagnetic iron oxide-enhanced mr imaging.
    Kim YK; Kim CS; Kwak HS; Lee JM
    J Magn Reson Imaging; 2004 Nov; 20(5):826-37. PubMed ID: 15503325
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Perfusion study of hypervascular hepatocellular carcinoma with SPIO.
    Saito K; Shindo H; Ozuki T; Ishikawa A; Kotake F; Shimazaki Y; Abe K
    Magn Reson Med Sci; 2005 Dec; 4(4):151-8. PubMed ID: 16543699
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of hypervascular malignant foci in borderline lesions of hepatocellular carcinoma: comparison of dynamic multi-detector row CT, dynamic MR imaging and superparamagnetic iron oxide-enhanced MR imaging.
    Shinmura R; Matsui O; Kadoya M; Kobayashi S; Terayama N; Sanada J; Demachi H; Gabata T
    Eur Radiol; 2008 Sep; 18(9):1918-24. PubMed ID: 18386012
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Imaging study of early hepatocellular carcinoma: usefulness of gadoxetic acid-enhanced MR imaging.
    Sano K; Ichikawa T; Motosugi U; Sou H; Muhi AM; Matsuda M; Nakano M; Sakamoto M; Nakazawa T; Asakawa M; Fujii H; Kitamura T; Enomoto N; Araki T
    Radiology; 2011 Dec; 261(3):834-44. PubMed ID: 21998047
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiarterial phase dynamic MRI of small early enhancing hepatic lesions in cirrhosis or chronic hepatitis: differentiating between hypervascular hepatocellular carcinomas and pseudolesions.
    Ito K; Fujita T; Shimizu A; Koike S; Sasaki K; Matsunaga N; Hibino S; Yuhara M
    AJR Am J Roentgenol; 2004 Sep; 183(3):699-705. PubMed ID: 15333358
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The pseudocapsule in hepatocellular carcinoma: correlation between dynamic MR imaging and pathology.
    Grazioli L; Olivetti L; Fugazzola C; Benetti A; Stanga C; Dettori E; Gallo C; Matricardi L; Giacobbe A; Chiesa A
    Eur Radiol; 1999; 9(1):62-7. PubMed ID: 9933382
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Timing of the hepatic arterial phase at Gd-EOB-DTPA-enhanced hepatic dynamic MRI: comparison of the test-injection and the fixed-time delay method.
    Nakamura S; Nakaura T; Kidoh M; Utsunomiya D; Doi Y; Harada K; Uemura S; Yamashita Y
    J Magn Reson Imaging; 2013 Sep; 38(3):548-54. PubMed ID: 23744782
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of test-injection method and fixed-time method for depiction of hepatocellular carcinoma using dynamic steady-state free precession magnetic resonance imaging.
    Shinozaki K; Yoshimitsu K; Irie H; Aibe H; Tajima T; Nishie A; Nakayama T; Kakihara D; Shimada M; Honda H
    J Comput Assist Tomogr; 2004; 28(5):628-34. PubMed ID: 15480036
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of hepatocellular carcinoma in patients with cirrhosis: MR imaging versus angiographically assisted helical CT.
    Kanematsu M; Hoshi H; Murakami T; Inaba Y; Kim T; Yamada T; Kato M; Yokoyama R; Nakamura H
    AJR Am J Roentgenol; 1997 Dec; 169(6):1507-15. PubMed ID: 9393154
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical Indication for Computed Tomography During Hepatic Arteriography (CTHA) in Addition to Dynamic CT Studies to Identify Hypervascularity of Hepatocellular Carcinoma.
    Fuji T; Nakamura Y; Fukumoto W; Kajiwara K; Chosa K; Tani C; Matsubara Y; Terada H; Honda Y; Arihiro K; Iida M; Baba Y; Awai K
    Cardiovasc Intervent Radiol; 2018 Apr; 41(4):618-627. PubMed ID: 29101449
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.